Chief Innovation Officer

Suzanne Sysko Clough, MD

Suzanne Sysko Clough, MD
Dr. Clough is responsible for defining the strategy for user and customer engagement initiatives and for the technology and data science product enhancements. Like her fellow ArmadaHealth® leaders, she is committed to improving healthcare delivery through innovation.

Suzanne is especially passionate about programs that deliver human-centric, evidence-based clinical and behavioral support to those touched by chronic disease. She was the Founder and Chief Medical Officer of WellDoc, a rapidly growing pioneer in the digital health technology company. WellDoc’s FDA-cleared app BlueStar® was the first in a novel class of therapy, called Mobile Prescription Therapy, for people with type 2 diabetes. At WellDoc, Clough led the clinical and behavioral algorithm design and development efforts of the WellDoc platform. She also played a key business development role, leading the launch of several commercially successful digital health products within the healthcare ecosystem.

Dr. Clough continues to be very involved in the digital health community, serving as an advisor to other digital health companies, including CanSurround, a personalized web/mobile technology for people living with cancer as well as serving as the Chief Medical Officer of AmalgamRx.

Her zeal for pursuing innovative, evidence-based solutions for chronic disease management was triggered by her medical background in endocrinology. Clough completed her training in internal medicine and a fellowship in endocrinology at the University of Maryland Medical Systems. She served as an assistant professor in the Division of Endocrinology as well as Medical Director and Founder of the Center for Weight Management and Wellness at the University of Maryland School of Medicine and Medical Systems. She received her Bachelor of Science degree in biology from James Madison University in Virginia.